When combined with a low-dose inhibitor of the soluble epoxide hydrolase (sEH), thereby stabilizing the epoxy compounds, EDPs’ effects were further strengthened, leading to an approximately 70% decrease in tumor growth and metastasis [61]. This evidence concerns the gene EPHX2 and neoplasm.